SARS-CoV-2 infection, inflammation and birth outcomes in a prospective NYC pregnancy cohort

• Published in: Journal of reproductive immunology Vol. 163; p. 104243
• Main Authors: Gigase, Frederieke A.J., Jessel, Rebecca H., Kaplowitz, Elianna, Boychuk, Natalie, Ohrn, Sophie, Ibroci, Erona, Castro, Juliana, Lynch, Jezelle, Tubassum, Rushna, Balbierz, Amy, Molenaar, Nina M., Graziani, Mara, Missall, Roy, Flores, Tammy, Stern, Toni, Carreno, Juan Manuel, Krammer, Florian, Adler, Alan, Brody, Rachel I., Lesseur, Corina, Chen, Jia, Ellington, Sascha, Galang, Romeo R., Snead, Margaret C., Howell, Elizabeth, Stone, Joanne, Bergink, Veerle, Dolan, Siobhan, Lieb, Whitney, Rommel, Anna-Sophie, de Witte, Lotje D., Janevic, Teresa
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier B.V 01-06-2024
• Subjects: Birthweight; Cytokines; HS-CRP; Inflammation; Preterm birth; SARS-CoV-2; SARS-CoV-2; Inflammation; Preterm birth; HS-CRP; Cytokines; Birthweight
• ISSN: 0165-0378; 1872-7603; 1872-7603
• DOI: 10.1016/j.jri.2024.104243

Associations between antenatal SARS-CoV-2 infection and pregnancy outcomes have been conflicting and the role of the immune system is currently unclear. This prospective cohort study investigated the interaction of antenatal SARS-CoV-2 infection, changes in cytokine and HS-CRP levels, birthweight and gestational age at birth. 2352 pregnant participants from New York City (2020–2022) were included. Plasma levels of interleukin (IL)-1β, IL-6, IL-17A and high-sensitivity C-reactive protein (HS-CRP) were quantified in blood specimens obtained across pregnancy. Quantile and linear regression models were conducted to 1) assess the impact of antenatal SARS-CoV-2 infection, overall and by timing of detection of SARS-CoV-2 positivity (< 20 weeks versus ≥ 20 weeks), on birthweight and gestational age at delivery; 2) examine the relationship between SARS-CoV-2 infection and maternal immune changes during pregnancy. All models were adjusted for maternal demographic and obstetric factors and pandemic timing. Birthweight models were additionally adjusted for gestational age at delivery and fetal sex. Immune marker models were also adjusted for gestational age at specimen collection and multiplex assay batch. 371 (15.8%) participants were infected with SARS-CoV-2 during pregnancy, of which 98 (26.4%) were infected at < 20 weeks gestation. Neither SARS-CoV-2 infection in general nor in early or late pregnancy was associated with lower birthweight nor earlier gestational age at delivery. Further, we did not observe cytokine or HS-CRP changes in response to SARS-CoV-2 infection and thus found no evidence to support a potential association between immune dysregulation and the diversity in pregnancy outcomes following infection.
•One of the largest investigations of immune markers after antenatal SARS-CoV-2 infection.•SARS-CoV-2 infection status was ascertained by various strategies to capture asymptomatic cases.•Antenatal SARS-CoV-2 infection does not result in maternal immune marker changes.•Antenatal SARS-CoV-2 infection is not associated with low birthweight or preterm birth.